purpose evaluate toxicity antitumor effect carbon ion radiotherapy hepatocellular carcinoma phase trial methods materials june NUMBER february NUMBER NUMBER patients histopathologically proven hepatocellular carcinoma treated NUMBER fractions NUMBER weeks doseescalation study disease stage stage ii NUMBER iiia NUMBER iva NUMBER patients common toxicity criteria radiation therapy oncology organization research treatment cancer criteria score used evaluate toxicity antitumor effect evaluated tumor response cumulative local control survival rates results median NUMBER months range months severe adverse effects deaths occurred score did increase NUMBER points start therapy NUMBER NUMBER patients score did increase NUMBER point early late phase respectively overall tumor response rate NUMBER local control overall survival rate NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER years respectively conclusion carbon ion radiotherapy appears safe effective patients hepatocellular carcinoma additional clinical studies using larger subject group required confirm therapeutic efficacy ii step wise child pugh follow NUMBER NUMBER treatment related child pugh group european